JBP Europe

Nanotechnology, registered patent Micron Sharpness.

World Leading Placental Extracts company.

JBP, Japan Bio Products Co., Ltd., was established in 1954 as specialized placenta company. We study and manufacture pharmaceutical products and cosmetics based on human placenta extract, and our placenta injection market share is about 80%.

We have studied human placenta application for more than 40 years and aim to learn more as technology develops.

JBP manufactures and sells the human placenta injection (Laennec) which was approved for cirrhosis treatment in Japan since 1974. JBP´s injection was being used widely as a Japanese typical Placenta injection for more than 30 years. Over the course of use there have been no reports of serious negative side effects.

Japan Bio Products, founded in Japan, is presently located at various locations worldwide, marketing a comprehensive of pharmaceutical and medical devices. Established in 2006, JBP China the main office located in Shangai has fully entered into the Chinese market.

Since 2011, we are also located in Europe, with main offices in Zurich, and sales distributors in several countries. We aim to open locations in many more countries in the years to come.

Translate »